Around the Practice


Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice

May 10th 2022

Expert panelists review key data from recent meetings on the management of multiple myeloma and consider how these can be applied to clinical practice.

Around the Practice: Adjuvant Therapy in NSCLC

April 29th 2022

A panel of experts review two patient cases to elucidate data in the adjuvant setting of non–small cell lung cancer.

Advances in Multiple Myeloma: Insights from Experts at Emory University on Translating Evidence to Clinical Practice

April 28th 2022

A panel of experts from Emory University review several key data updates in multiple myeloma from recent meetings and discuss how the data can be applied to clinical practice to improve patient outcomes.

Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer: Translating Evidence to Clinical Practice

April 18th 2022

Drs. Sara Hurvitz, Stefania Maraka, and Ruta Rao discuss the evolving landscape of metastatic HER2+ breast cancer, highlighting recent clinical trials and the management of patients with brain metastases.

2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates

April 15th 2022

Expert panelists focus on a patient profile of metastatic urothelial cancer, discuss strategies and challenges for maintenance therapy, and comment on how recent clinical trial data presented at the 2022 ASCO Genitourinary Cancers Symposium may impact clinical practice for patients with the disease.

Around the Practice: Chronic GVHD Treatment Advances

April 7th 2022

A panel of experts in stem cell transplant and cellular immunotherapy builds a lively discussion on current and emerging treatment options for the management of acute and chronic graft versus host disease.

Prostate Cancer: Androgen Deprivation Therapy Updates

April 6th 2022

Expert panelists center discussion around two patient cases to review use of newer anti-androgen deprivation therapy in the management of prostate cancer.

Evidence-Based Strategies to Improve Outcomes in Advanced RCC

March 28th 2022

Experts center their discussion on patient profiles to highlight recent advances in the treatment of renal cell carcinoma and how they apply evidence from research into clinical practice to optimize patient outcomes.

Recent Advances in the Treatment of Multiple Myeloma: Highlights from the ASH 2021 Meeting

March 25th 2022

A panel of experts provides a discussion on treatments for newly diagnosed transplant eligible, transplant ineligible, and relapsed multiple myeloma, and how recent clinical trial data presented at ASH 2021 can be applied to clinical practice.

Multidisciplinary Management of HER2+ Breast Cancer

December 22nd 2021

Various healthcare professionals join to discuss the management of a patient diagnosed with HER2-positive breast cancer and consider how to best approach the patient with newer treatment strategies through her continuum of care.